Low body weight and involuntary weight loss are associated with Raynaud’s phenomenon in both men and women

References

• Fraenkel L, Zhang Y, Chaisson CE, Maricq HR, Evans SR, Brand F, et al. Different factors influencing the expression of Raynaud’s phenomenon in men and women. Arthritis Rheum 1999;42:306–10.
   PubMed Web of Science ®Google Scholar
• Herrick AL. Pathogenesis of Raynaud’s phenomenon. Rheumatology (Oxford) 2005;44:587–96.
   PubMed Web of Science ®Google Scholar
• Yucel B, Kubat Uzum A, Ozbey N, Kamali S, Yager J. Anorexia nervosa and Raynaud’s phenomenon: A case report. Int J Eat Disord 2007;40:762–5.
   PubMed Web of Science ®Google Scholar
• Sachs KV, Harnke B, Mehler PS, Krantz MJ. Cardiovascular complications of anorexia nervosa: A systematic review. Int J Eat Disord 2016;49:238–48.
   PubMed Web of Science ®Google Scholar
• De Martinis M, Sirufo MM, Ginaldi L. Raynaud’s phenomenon and nailfold capillaroscopic findings in anorexia nervosa. Curr Med Res Opin 2018;34:547–50.
   PubMed Web of Science ®Google Scholar
• Stolk RP, Rosmalen JGM, Postma DS, De Boer RA, Navis G, Slaets JPJ, et al. Universal risk factors for multifactorial diseases: LifeLines: a three-generation population-based study. Eur J Epidemiol 2008;23:67–74.
   PubMed Web of Science ®Google Scholar
• Karlson EW, Sanchez-Guerrero J, Wright EA, Lew RA, Daltroy LH, Katz JN, et al. A connective tissue disease screening questionnaire for population studies. Ann Epidemiol 1995;5:297–302.
   PubMedGoogle Scholar
• Karlson EW, Costenbader KH, McAlindon TE, Massarotti EM, Fitzgerald LM, Jajoo R, et al. High sensitivity, specificity and predictive value of the connective tissue disease screening questionnaire among urban African-American women. Lupus 2005;14:832–6.
   PubMed Web of Science ®Google Scholar
• Brennan P, Silman A, Black C, Bernstein R, Coppock J, Maddison P, et al. Validity and reliability of three methods used in the diagnosis of Raynaud’s phenomenon. Rheumatology (Oxford) 1993;32:357–61.
   Web of Science ®Google Scholar
• Vinke PC, Corpeleijn E, Dekker LH, Jacobs DR, Navis G, Kromhout D. Development of the food-based Lifelines Diet Score (LLDS) and its application in 129,369 Lifelines participants. Eur J Clin Nutr 2018;72:1111–19.
   PubMed Web of Science ®Google Scholar
• Brinkworth GD, Noakes M, Buckley JD, Keogh JB, Clifton PM. Long-term effects of a very-low-carbohydrate weight loss diet compared with an isocaloric low-fat diet after 12 mo. Am J Clin Nutr 2009;90:23–32.
   PubMed Web of Science ®Google Scholar
• Tobias DK, Chen M, Manson JAE, Ludwig DS, Willett W, Hu FB. Effect of low-fat diet interventions versus other diet interventions on long-term weight change in adults: A systematic review and meta-analysis. Lancet Diabetes Endocrinol 2015;3:968–79.
   PubMed Web of Science ®Google Scholar
• Samaha FF, Iqbal N, Seshadri P, Chicano KL, Daily DA, McGrory J, et al. A low-carbohydrate as compared with a low-fat diet in severe obesity. N Engl J Med 2003;348:2074–81.
   PubMed Web of Science ®Google Scholar
• Schutte JE, Longhurst JC, Gaffney FA, Bastian BC, Blomqvist CG. Total plasma creatinine: an accurate measure of total striated muscle mass. J Appl Physiol Respir Environ Exerc Physiol 1981;51:762–6.
   PubMed Web of Science ®Google Scholar
• Thongprayoon C, Cheungpasitporn W, Kashani K. Serum creatinine level, a surrogate of muscle mass, predicts mortality in critically ill patients. J Thorac Dis 2016;8:E305–11.
   PubMed Web of Science ®Google Scholar
• Soini S, Mustajoki P, Eriksson JG. Lifestyle-related factors associated with successful weight loss. Ann Med 2015;47:88–93.
   PubMed Web of Science ®Google Scholar
• Pansini F, Cervellati C, Guariento A, Stacchini MA, Castaldini C, Bernardi A, et al. Oxidative stress, body fat composition, and endocrine status in pre- and postmenopausal women. Menopause 2008;15:112–18.
   PubMed Web of Science ®Google Scholar
• Jakubowicz D, Barnea M, Wainstein J, Froy O. High caloric intake at breakfast vs. dinner differentially influences weight loss of overweight and obese women. Obesity 2013;21:2504–12.
   PubMed Web of Science ®Google Scholar
• Wysokiński A, Sobów T, Kłoszewska I, Kostka T. Mechanisms of the anorexia of aging—a review. Age (Omaha) 2015;37:9821.
   PubMed Web of Science ®Google Scholar
• Houben AJ, Eringa EC, Jonk AM, Serne EH, Smulders YM, Stehouwer CD. Perivascular fat and the microcirculation: relevance to insulin resistance, diabetes, and cardiovascular disease. Curr Cardiovasc Risk Rep 2012;6:80–90.
   PubMedGoogle Scholar
• Park D, Lee JH, Han S. Underweight: another risk factor for cardiovascular disease? Med (United States) 2017;96:e8769.
   Google Scholar
• Srikanthan P, Horwich TB, Tseng CH. Relation of muscle mass and fat mass to cardiovascular disease mortality. Am J Cardiol 2016;117:1355–60.
   PubMed Web of Science ®Google Scholar
• Siguel EN, Lerman RH. Role of essential fatty acids: dangers in the US department of agriculture dietary recommendations (“pyramid”) and in low-fat diets. Am J Clin Nutr 1994;60:973–4.
   PubMed Web of Science ®Google Scholar
• Garner R, Kumari R, Lanyon P, Doherty M, Zhang W. Prevalence, risk factors and associations of primary Raynaud’s phenomenon: systematic review and meta-analysis of observational studies. BMJ Open 2015;5:e006389.
   PubMed Web of Science ®Google Scholar
• Bartelink ML, Wollersheim H, van de Lisdonk E, Spruijt R, van Weel C. Prevalence of Raynaud’s phenomenon. Neth J Med 1992;41:149–52.
   PubMed Web of Science ®Google Scholar
• Purdie G, Harrison A, Purdie D. Prevalence of Raynaud’s phenomenon in the adult New Zealand population. NZ Med J 2009;122:55–62.
   PubMedGoogle Scholar
• Maricq HR, Carpentier PH, Weinrich MC, Keil JE, Palesch Y, Biro C, et al. Geographic variation in the prevalence of Raynaud’s phenomenon: a 5 region comparison. J Rheumatol 1997;24:879–89.
   PubMed Web of Science ®Google Scholar
• Brand FN, Larson MG, Kannel WB, McGuirk JM. The occurrence of Raynaud’s phenomenon in a general population: the Framingham study. Vasc Med 1997;2:296–301.
   PubMedGoogle Scholar
• Román Ivorra JA, Gonzálvez Perales JL, Fernández Carballido C, Graña J, Torres MJ. Prevalence of Raynaud’s phenomenon in general practice in the East of Spain. Clin Rheumatol 2001;20:88–90.
   PubMed Web of Science ®Google Scholar
• De Angelis R, Salaffi F, Grassi W. Raynaud’s phenomenon: prevalence in an Italian population sample. Clin Rheumatol 2006;25:506–10.
   PubMed Web of Science ®Google Scholar
• Onbaşi K, Şahin Í, Onbaşi O, Üstün Y, Koca D. Raynaud’s phenomenon in a healthy Turkish population. Clin Rheumatol 2005;24:365–9.
   PubMed Web of Science ®Google Scholar
• Herrick AL. The pathogenesis, diagnosis and treatment of Raynaud phenomenon. Nat Rev Rheumatol 2012;8:469–79.
   PubMed Web of Science ®Google Scholar
• Maverakis E, Patel F, Kronenberg DG, Chung L, Fiorentino D, Allanore Y, et al. International consensus criteria for the diagnosis of Raynaud’s phenomenon. J Autoimmun 1999;42:60–5.
   Google Scholar
• Wigley FM. Raynaud’s phenomenon. N Engl J Med 2002;347:1001–8.
   PubMed Web of Science ®Google Scholar
• Smith V, Vanhaecke A, Herrick AL, Distler O, Guerra MG, Denton CP, et al. Fast track algorithm: how to differentiate a “scleroderma pattern” from a “non-scleroderma pattern”. Autoimmun Rev 2019;18:102394.
   PubMed Web of Science ®Google Scholar
• Smith V, Herrick AL, Ingegnoli F, Damjanov N, De Angelis R, Denton CP, et al. Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud’s phenomenon and systemic sclerosis. Autoimmun Rev 2020;19:102458.
   PubMed Web of Science ®Google Scholar
• Lis-Świȩty A. Recent advances in the workup and management of Raynaud phenomenon. Polish Arch Intern Med 2019;129:798–808.
   PubMedGoogle Scholar